SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000059478-21-000216
Filing Date
2021-10-27
Accepted
2021-10-27 09:06:59
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lly-20210930.htm   iXBRL 10-Q 2912882
2 EX-31.1 lly-9302021x10qxexhibit311.htm EX-31.1 10805
3 EX-31.2 lly-9302021x10qxexhibit312.htm EX-31.2 10780
4 EX-32 lly-9302021x10qxexhibit32.htm EX-32 7217
  Complete submission text file 0000059478-21-000216.txt   12387193

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20210930.xsd EX-101.SCH 55760
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20210930_cal.xml EX-101.CAL 75023
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20210930_def.xml EX-101.DEF 275499
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20210930_lab.xml EX-101.LAB 652732
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20210930_pre.xml EX-101.PRE 413723
10 EXTRACTED XBRL INSTANCE DOCUMENT lly-20210930_htm.xml XML 3246265
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 211350953
SIC: 2834 Pharmaceutical Preparations